Drugs commonly used in rheumatology, the JAK inhibitors, are opening up treatment options for people with autoimmune-driven hair loss, and new mechanistic knowledge is also helping scientists tackle androgenic alopecia, the commonest cause of baldness.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harrison, C. Hair loss treatments take aim at the immune system. Nat Biotechnol 41, 1179–1181 (2023). https://doi.org/10.1038/s41587-023-01939-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01939-w
- Springer Nature America, Inc.